Molecule Details
| InChIKey | UBNMGTSDHSQBEL-PMERELPUSA-N |
|---|---|
| Compound Name | Ce-326597 |
| Canonical SMILES | CC(C)N(Cc1ccccc1)C(=O)CN1C(=O)[C@@H](Cc2c[nH]c3ccccc23)c2nnc(-c3ccccc3)n2-c2ccccc21 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 2 |
| Pfam Stratification | Homologous |
| Avg pChEMBL | 7.12 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile
DrugBank Annotations
| DrugBank ID | DB12694 |
|---|---|
| Drug Name | CE-326597 |
| CAS Number | 870615-40-0 |
| Groups | investigational |
| ATC Codes | nan |
| Description | CE-326,597 has been used in trials studying the treatment of Obesity. |
Categories: Benzazepines Heterocyclic Compounds, Fused-Ring
Cross-references: BindingDB: 50329179 CHEMBL1269258 ChemSpider: 26362286 PubChem:52949124 PubChem:347828895
Target Activities (2)
DrugBank Target Actions (1)
| Target | Gene | Target Name | Action | Type |
|---|---|---|---|---|
| P32238 | CCKAR | Cholecystokinin receptor type A | agonist | targets |